The first approved CRISPR medicine has now shown similarly strong results in children as young as five years old with sickle cell disease and...
Some of the best links we picked up around the internet
CRISPR Therapeutics has presented preclinical data showing that its investigational therapy CTX460 can correct the SERPINA1 Z (E342K) mutation...